Download Citation
Article Source:
Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study
Lee W,
Sheehan C,
Chye R,
Chang S,
Bayes A,
et al.
(2023)
Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study.
PLOS ONE 18(11): e0290876.
https://doi.org/10.1371/journal.pone.0290876